Why Investors Are Psyched About Psychedelic Stocks
by visualcapitalist The Briefing Plenty of psychedelic stocks have experienced triple-digit returns in the last year Optimism is brewing as governments grant research approvals for the study of psychedelics on mental health By some estimates, the psychedelic drugs market is projected to see compound annual growth (CAGR) of 16.3% to reach $6.85 billion by 2027 Psyched About Psychedelics Psychedelic stocks are trading … Read more